1995
DOI: 10.1093/jat/19.6.419
|View full text |Cite
|
Sign up to set email alerts
|

A Reliable Method for the Detection, Confirmation, and Quantitation of Cannabinoids in Blood

Abstract: A sensitive and reliable method was developed for the identification and quantitation of cannabinoids in blood. Samples were screened by fluorescence polarization immunoassay. Analysis was completed on a benchtop mass selective detector using selected ion monitoring. The limits of detection were 0.2 ng/mL for delta9-tetrahydrocannabinol (THC and 11-hydroxy-THC and 2 ng/mL for 11-nor-9-carboxy-THC. Extensive method validation is presented, including within-run variation, between-run variation, and results from … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
1
1
1
1

Citation Types

0
6
0

Year Published

1997
1997
2016
2016

Publication Types

Select...
5
4
1

Relationship

0
10

Authors

Journals

citations
Cited by 31 publications
(6 citation statements)
references
References 16 publications
0
6
0
Order By: Relevance
“…The assay validation was undertaken by Advanced Bioanalytical Service Laboratories (London, UK), who developed the technique after reviewing the literature, which was based on the methodology adopted by three different groups (Foltz et al 1983; Goodall & Basteyns 1995; Kemp et al 1995), and designed with reference to FDA guidelines for industry (FDA Guidance for Industry 2012). The method utilised protein precipitation, solvent extraction and derivatisation for the sample preparation and then sample analysis by capillary gas chromatography and detection by a mass spectrometer (GC-MS).…”
Section: Methodsmentioning
confidence: 99%
“…The assay validation was undertaken by Advanced Bioanalytical Service Laboratories (London, UK), who developed the technique after reviewing the literature, which was based on the methodology adopted by three different groups (Foltz et al 1983; Goodall & Basteyns 1995; Kemp et al 1995), and designed with reference to FDA guidelines for industry (FDA Guidance for Industry 2012). The method utilised protein precipitation, solvent extraction and derivatisation for the sample preparation and then sample analysis by capillary gas chromatography and detection by a mass spectrometer (GC-MS).…”
Section: Methodsmentioning
confidence: 99%
“…Blood samples (1 ml) for the Δ 9 -THC identification were analyzed by liquid/liquid extraction using the method validated by Goodall and Basteyns [14].…”
Section: Sample Collection and Analysismentioning
confidence: 99%
“…Detection and quantification of cannabinoids in blood were performed as previously described with minor modifications [14,15]. Deuterated tetrahydrocannabinol (THC-d3), deuterated 11-hydroxy-THC (11-OH-THC-d3) and deuterated 11-nor-9-carboxy-THC (THCCOOH-d3) were used as internal standards.…”
Section: Drug Detection Processmentioning
confidence: 99%